Related Experiment Video
Updated: Aug 24, 2026

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
Published on: March 30, 2017
A complementary combination of delivery device and drug formulation for inhalation therapy in preschool children
Karen G Schüepp1, Sunalene Devadson, Christina Roller
1Swiss Paediatric Respiratory Research Group, Division of Respirtatory Medicine, University Children's Hospital, Zurich, Switzerland.
Insights
A new perforated vibrating membrane nebuliser significantly improved lung drug delivery in preschool children. This optimized device delivered 36-38% budesonide to the lungs, a substantial increase from conventional nebulisers (max 8%).
Area of Science:
- Pediatric Pulmonology
- Respiratory Drug Delivery
- Pharmacokinetics
Background:
- Inhalation therapy in preschool children often suffers from low lung drug deposition.
- Conventional nebulisers show limited efficiency in delivering medication to the lungs of young children.
Purpose of the Study:
- To evaluate the lung delivery efficiency of an optimized combination of a perforated vibrating membrane nebuliser and budesonide formulation in preschool children.
- To compare this novel system with a conventional nebuliser for budesonide delivery.
Main Methods:
- A comparative study involving six three-year-old children.
- Radiolabelled budesonide solutions were administered using a conventional nebuliser (MMD 4.2 mm) and a perforated vibrating membrane nebuliser (MMD 2.5 mm).
- Lung deposition was quantified for both devices.
Main Results:
- The perforated vibrating membrane nebuliser achieved significantly higher lung deposition of budesonide (36% and 38%).
- Conventional nebulisers demonstrated markedly lower lung deposition, with a maximum of 8%.
Conclusions:
- Optimized combinations of delivery devices and drug formulations can substantially improve inhaled therapy efficacy in preschool children.
- Perforated vibrating membrane nebulisers represent a promising advancement for efficient inhalation therapy in this pediatric population.
Abstract:
The amount of drug delivered from commercially available inhalation devices which reaches the lungs of preschool children is generally low. We therefore studied the efficiency of lung delivery from an optimised combination of delivery device and drug formulation based on individual patient-related factors. In six three-year-old children we compared the delivery of a radiolabelled budesonide solution with a MMD of 4.2 mm from a conventional nebuliser, with that of a radiolabelled budesonide solution with a MMD of 2.5 mm from a perforated vibrating membrane nebuliser. Lung deposition of budesonide delivered from the perforated vibrating membrane nebuliser was 36% and 38% and notably higher than from a conventional nebuliser (maximum 8%). The development of complementary combinations of delivery devices and drug formulations to meet the needs of efficient inhalation therapy in preschool children seems to be a good way of improving the efficacy of inhaled therapy in this age group.
Related Concept Videos
Inhaled Medications
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Drug Dosing: Infants and Children
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

